OFIX vs. SRDX, ANGO, ARAY, ATRC, ATEC, IRMD, PLSE, OSUR, SKIN, and EMBC
Should you be buying Orthofix Medical stock or one of its competitors? The main competitors of Orthofix Medical include Surmodics (SRDX), AngioDynamics (ANGO), Accuray (ARAY), AtriCure (ATRC), Alphatec (ATEC), Iradimed (IRMD), Pulse Biosciences (PLSE), OraSure Technologies (OSUR), Beauty Health (SKIN), and Embecta (EMBC). These companies are all part of the "medical" sector.
Orthofix Medical (NASDAQ:OFIX) and Surmodics (NASDAQ:SRDX) are both small-cap medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, valuation, dividends, analyst recommendations, profitability, media sentiment, institutional ownership, community ranking and earnings.
Orthofix Medical currently has a consensus price target of $15.50, indicating a potential upside of 19.00%. Surmodics has a consensus price target of $57.00, indicating a potential upside of 71.02%. Given Surmodics' stronger consensus rating and higher possible upside, analysts clearly believe Surmodics is more favorable than Orthofix Medical.
Orthofix Medical has a beta of 1.04, suggesting that its stock price is 4% more volatile than the S&P 500. Comparatively, Surmodics has a beta of 1.01, suggesting that its stock price is 1% more volatile than the S&P 500.
In the previous week, Surmodics had 8 more articles in the media than Orthofix Medical. MarketBeat recorded 10 mentions for Surmodics and 2 mentions for Orthofix Medical. Surmodics' average media sentiment score of 0.32 beat Orthofix Medical's score of -0.15 indicating that Surmodics is being referred to more favorably in the news media.
Surmodics has lower revenue, but higher earnings than Orthofix Medical. Orthofix Medical is trading at a lower price-to-earnings ratio than Surmodics, indicating that it is currently the more affordable of the two stocks.
89.8% of Orthofix Medical shares are owned by institutional investors. Comparatively, 96.6% of Surmodics shares are owned by institutional investors. 4.7% of Orthofix Medical shares are owned by company insiders. Comparatively, 8.9% of Surmodics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.
Surmodics has a net margin of 3.99% compared to Orthofix Medical's net margin of -20.28%. Surmodics' return on equity of 8.06% beat Orthofix Medical's return on equity.
Orthofix Medical received 73 more outperform votes than Surmodics when rated by MarketBeat users. However, 67.07% of users gave Surmodics an outperform vote while only 61.78% of users gave Orthofix Medical an outperform vote.
Summary
Surmodics beats Orthofix Medical on 15 of the 18 factors compared between the two stocks.
Get Orthofix Medical News Delivered to You Automatically
Sign up to receive the latest news and ratings for OFIX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OFIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Orthofix Medical Competitors List
Related Companies and Tools
